FDA — authorised 27 April 2007
- Application: NDA022051
- Marketing authorisation holder: HALEON US HOLDINGS
- Local brand name: FLONASE SENSIMIST ALLERGY RELIEF
- Indication: SPRAY, METERED — NASAL
- Status: approved
🇺🇸 Fluticasone Furoate (FF) in United States
FDA authorised Fluticasone Furoate (FF) on 27 April 2007
Marketing authorisation
Fluticasone Furoate (FF) in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Respiratory / Pulmonology approved in United States
Frequently asked questions
Is Fluticasone Furoate (FF) approved in United States?
Yes. FDA authorised it on 27 April 2007.
Who is the marketing authorisation holder for Fluticasone Furoate (FF) in United States?
HALEON US HOLDINGS holds the US marketing authorisation.